<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">8679443</article-id><article-id pub-id-type="pmc">2074604</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tavassoli</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Steingrimsdottir</surname><given-names>H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pierce</surname><given-names>E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>X.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Alagoz</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Farzaneh</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Campbell</surname><given-names>I. G.</given-names></name></contrib></contrib-group><aff>Rayne Institute, King's College School of Medicine and Dentistry, London, UK.</aff><pub-date pub-type="ppub"><month>7</month><year>1996</year></pub-date><volume>74</volume><issue>1</issue><fpage>115</fpage><lpage>119</lpage><abstract><p>Forty-nine ovarian tumours were examined for loss of heterozygosity (LOH) on chromosome 5 using eight microsatellite markers spanning both arms, including one at the APC locus. LOH on 5q was a frequent event, detectable in 23 of 49 (47%) tumours, whereas 5p LOH was detected in only 1 of 22 tumours (5%). Six tumours showed partial LOH on 5q, enabling the candidate region to be localised to a 22 cM region proximal to APC, flanked by D5S424 and D5S644. An association was found between 5q LOH and TP53 mutation, with 18 of 23 (78%) tumours with LOH on 5q also harbouring a TP53 mutation. LOH on 5q was observed in 6 of 18 (33%) stage I tumours, suggesting that it may be an early event in the molecular pathogenesis of certain ovarian carcinomas.</p><sec sec-type="scanned-figures"><title>Images</title><fig id="F1"><label>Figure 1</label><graphic xlink:href="brjcancer00017-0120-a" xlink:role="116"/></fig></sec></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00017-0119.tif" xlink:title="scanned-page" xlink:role="115" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00017-0120.tif" xlink:title="scanned-page" xlink:role="116" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00017-0121.tif" xlink:title="scanned-page" xlink:role="117" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00017-0122.tif" xlink:title="scanned-page" xlink:role="118" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00017-0123.tif" xlink:title="scanned-page" xlink:role="119" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

